ALTAIR Investigators. Efficacy and safety of intravitreal aflibercept treat-and-extend regimens in exudative age-related macular degeneration: 52- and 96-week findings from ALTAIR: a randomized controlled trial - Ohji, M; Takahashi, K; Okada, A A (Adv Ther, 2020)